Acute pancreatitis as a possible consequence of metronidazole during a relapse of ulcerative colitis

European Journal of Gastroenterology and Hepatology

Volumn 19, Issue 9, 2007, Pages 805-806

  Tsesmeli, Niki E ^a,b   Giannoulis, Kleanthis E ^b   Savopoulos, Christos G ^a   Vretou, Eleni E ^c   Ekonomou, Ippoliti A ^a   Giannoulis, Elefterios K ^a  

^a AHEPA UNIVERSITY HOSPITAL   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c ARISTOTLE UNIVERSITY MEDICAL SCHOOL   (Greece)

Author keywords

5 aminosalicylic acid; Inflammatory bowel disease; Mesalamine; Metronidazole; Pancreatitis; Ulcerative colitis

Indexed keywords

MESALAZINE; METRONIDAZOLE; PREDNISOLONE;

ACUTE PANCREATITIS; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; ENTERITIS; HUMAN; LABORATORY TEST; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; REMISSION; ULCERATIVE COLITIS;

EID: 34547958958     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e328133f2fb     Document Type: Article

References (10)

1. Eland IA, van Puijenbroek EP, Sturkenboom MJ, Wilson JH, Stricker BH. Drug-associated acute pancreatitis: twenty-years of spontaneous reporting in the Netherlands. Am J Gastroenterol 1999; 94:2417-2422.
2. Nigwekar SU, Casey KJ. Metronidazole-induced pancreatitis. A case report and review of literature. JOP 2004; 10:516-519.
3. Munk EM, Pedersen L, Floyd A, Norgard B, Rasmussen HH, Sorensen HT. Inflammatory bowel diseases, 5-aminosalicylic acid and sulfasalazine treatment and risk of acute pancreatitis: a population-based case-control study. Am J Gastroenterol 2004; 99:884-888.
4. Inoue H, Shiraki K, Okano H, Deguchi M, Yamanaka T, Sakai T, et al. Acute pancreatitis in patients with ulcerative colitis. Dig Dis Sci 2005; 50:1064-1067.
5. Trivedi CD, Pitchumoni CS. Drug-induced pancreatitis: an update. J Clin Gastroenterol 2005; 39:709-716.
6. Lancashire RJ, Cheng K, Langman MJ. Discrepancies between population-based data and adverse reaction reports in assessing drugs as causes of acute pancreatitis. Aliment Pharmacol Ther 2003; 17:887-893.
7. Blomgren KB, Sundstrom A, Steineck G, Genell S, Sjostedt S, Wiholm BE. A Swedish case-control network for studies of drug-induced morbidity acute pancreatitis. Eur J Clin Pharmacol 2002; 58:275-283.
8. Daniel F, Seksik P, Cacheux W, Jian R, Marteau P. Tolerance of 4-aminosalicylic acid enemas in patients with inflammatory bowel disease and 5-aminosalicylic-induced acute pancreatitis. Inflamm Bowel Dis 2004; 10:258-260.
9. Toubanakis C, Batziou E, Sipsas N, Galanopoulos G, Tzivras M, Archimandritis A. Acute pancreatitis after long-term therapy with mesalazine and hyperamylasaemia associated with azathioprine in a patient with ulcerative colitis. Eur J Gastroenterol Hepatol 2003; 15:933-934.
10. Norgaard M, Ratanajamit C, Jacobsen J, Skriver MV, Pedersen L, Sorensen HT. Metronidazole and risk of acute pancreatitis: a population-based case-control study. Aliment Pharmacol Ther 2005; 21:415-420.